ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, TransMedics Group, Inc. (TMDX) shows an Average True Range (ATR) of 5.76 and an Enterprise Value of 3.03B. Its average trading volume over the past 3 months is 971.52K, indicating liquidity. These fundamental metrics provide insight into TMDX's underlying financial health and market activity.
TransMedics Group, Inc. (TMDX) technical indicators as of July 20, 2025: the SMA 20 is -11.27%, SMA 50 at -12.51%, and SMA 200 at 18.04%. The RSI 14 value is 33.58, suggesting its current momentum. These technical analysis signals help assess TMDX's price trends and potential future movements.
TransMedics Group, Inc. (TMDX) stock performance overview as of July 20, 2025: The 52-week high is $177.37 (currently -38.05% below), and the 52-week low is $55 (currently 99.78% above). Over the past year, TMDX's performance is -23.88%, compared to the S&P 500's 13.57% change.
According to market data, TransMedics Group, Inc. (TMDX) stock's recent performance metrics show that over the last month, TMDX is -19.32%, with a Year-to-Date (YTD) performance of 76.23%. Over the past year, the stock has seen a -23.88% change. These figures summarize TMDX's price movements across various periods, reflecting its historical returns.
According to current financial data, TMDX stock's P/E (TTM) ratio is 75.70, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TMDX, including P/S (7.61), P/B (13.91), and P/FCF (-58.80), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.